We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

143 hedge funds and large institutions have $162M invested in Niagen Bioscience in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 49 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 49

5.43% more ownership

Funds ownership: 40.37% → 45.8% (+5.4%)

15% less funds holding

Funds holding: 169 → 143 (-26)

21% less capital invested

Capital invested by funds: $205M → $162M (-$42.7M)

50% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 46

71% less call options, than puts

Call options by funds: $615K | Put options by funds: $2.09M

Holders
143
Holders Change
-26
Holders Change %
-15.38%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
54
Reduced
49
Closed
46
Calls
$615K
Puts
$2.09M
Net Calls
-$1.48M
Net Calls Change
+$370K

Top Buyers

1
SW
SteelPeak Wealth
California
+$18.2M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.11M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$3.52M
4
SEI Investments
SEI Investments
Pennsylvania
+$3.19M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$2.3M

Top Sellers

1
AG
Algert Global
California
-$3.65M
2
Morgan Stanley
Morgan Stanley
New York
-$2.69M
3
N
Nuveen
North Carolina
-$1.99M
4
Jane Street
Jane Street
New York
-$1.93M
5
Ameriprise
Ameriprise
Minnesota
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lazard Asset Management
151
Lazard Asset Management
New York
– -$613K -96,359 Closed
BCM
152
Bridgeway Capital Management
Texas
– -$427K -67,179 Closed
Tudor Investment Corp
153
Tudor Investment Corp
Connecticut
– -$360K -56,536 Closed
ACM
154
Aquatic Capital Management
Illinois
– -$355K -55,851 Closed
AA
155
ALPS Advisors
Colorado
– -$305K -47,978 Closed
Verition Fund Management
156
Verition Fund Management
Connecticut
– -$287K -45,066 Closed
VI
157
Versor Investments
New York
– -$269K -42,300 Closed
SO
158
STRS Ohio
Ohio
– -$266K -41,900 Closed
Man Group
159
Man Group
United Kingdom
– -$172K -27,105 Closed
CIP
160
Cornerstone Investment Partners
Georgia
– -$158K -24,875 Closed
Janus Henderson Group
161
Janus Henderson Group
United Kingdom
– -$155K -24,367 Closed
IAA
162
Independent Advisor Alliance
North Carolina
– -$154K -24,260 Closed
Universal-Beteiligungs- und Servicegesellschaft
163
Universal-Beteiligungs- und Servicegesellschaft
Germany
– -$147K -23,084 Closed
AWM
164
Axxcess Wealth Management
California
– -$145K -22,834 Closed
Zurich Cantonal Bank
165
Zurich Cantonal Bank
Switzerland
– -$142K -22,300 Closed
BFM
166
Boothbay Fund Management
New York
– -$133K -20,849 Closed
NA
167
NewEdge Advisors
Louisiana
– -$126K -19,779 Closed
QC
168
Quadrature Capital
United Kingdom
– -$104K -16,367 Closed
ASRS
169
Arizona State Retirement System
Arizona
– -$98.8K -15,540 Closed
Two Sigma Advisers
170
Two Sigma Advisers
New York
– -$87.8K -13,800 Closed
A
171
AlphaQuest
New York
– -$87.1K -13,688 Closed
AC
172
AXQ Capital
New Jersey
– -$86.7K -13,636 Closed
MAM
173
Martingale Asset Management
Massachusetts
– -$84.9K -13,351 Closed
SC
174
SummitTX Capital
Texas
– -$78.6K -12,361 Closed
KK
175
KLP Kapitalforvaltning
Norway
– -$73.1K -11,500 Closed
4 5 6
7
8

NAGE Hedge Fund Activity: Q1 2026 in Review

143 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q1 2026, worth a combined $162M — down 21% from $205M a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of NAGE and 23 opened new positions — a net loss of 23 holders — while 49 trimmed existing stakes and 54 added.

The largest buyer was SteelPeak Wealth, opening a new position worth an estimated $18.2M. The largest seller was Algert Global, exiting entirely with an estimated $3.65M sold.

  • 143 institutional investors held Niagen Bioscience (NAGE) as of Q1 2026, down from 169 in Q4 2025.
  • Funds reported $162M of Niagen Bioscience stock for Q1 2026, down 21% quarter-over-quarter.
  • 23 funds opened new Niagen Bioscience positions in Q1 2026 and 46 closed out, a net change of -23 holders.
  • The largest Niagen Bioscience buyer in Q1 2026 was SteelPeak Wealth, an estimated $18.2M added.
  • The largest Niagen Bioscience seller in Q1 2026 was Algert Global, an estimated $3.65M sold.

Based on aggregated 13F filings for Q1 2026.